聚乙二醇干扰素联合利巴韦林治疗丙型肝炎病毒/人类免疫缺陷病毒合并感染患者后肝纤维化的消退情况 - Suppr

Suppr

超能文献

Regression of liver fibrosis in hepatitis C virus/HIV-co-infected patients after treatment with pegylated interferon plus ribavirin.

作者信息

Soriano Vincent, Labarga Pablo, Ruiz-Sancho Andrés, Garcia-Samaniego Javier, Barreiro Pablo

出版信息

AIDS. 2006 Nov 14;20(17):2225-7. doi: 10.1097/01.aids.0000247583.38943.95.

DOI:10.1097/01.aids.0000247583.38943.95

PMID:17086063

Abstract

摘要

相似文献

Regression of liver fibrosis in hepatitis C virus/HIV-co-infected patients after treatment with pegylated interferon plus ribavirin.聚乙二醇干扰素联合利巴韦林治疗丙型肝炎病毒/人类免疫缺陷病毒合并感染患者后肝纤维化的消退情况

AIDS. 2006 Nov 14;20(17):2225-7. doi: 10.1097/01.aids.0000247583.38943.95.

Peginterferon plus ribavirin for hepatitis C in HIV-infected patients.

N Engl J Med. 2004 Nov 25;351(22):2340-2; author reply 2340-2. doi: 10.1056/NEJM200411253512220.

Peginterferon plus ribavirin for hepatitis C in HIV-infected patients.

N Engl J Med. 2004 Nov 25;351(22):2340-2; author reply 2340-2.

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.聚乙二醇化干扰素α-2b与标准干扰素α-2b联合利巴韦林治疗HIV感染患者慢性丙型肝炎的随机对照试验。

JAMA. 2004 Dec 15;292(23):2839-48. doi: 10.1001/jama.292.23.2839.

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.聚乙二醇干扰素α-2a联合利巴韦林用于治疗HIV感染患者的慢性丙型肝炎病毒感染

N Engl J Med. 2004 Jul 29;351(5):438-50. doi: 10.1056/NEJMoa040842.

Treatment of chronic hepatitis C in human immunodeficiency virus/hepatitis C virus-coinfected patients in the era of pegylated interferon and ribavirin.聚乙二醇干扰素和利巴韦林时代人类免疫缺陷病毒/丙型肝炎病毒合并感染患者的慢性丙型肝炎治疗

Semin Liver Dis. 2005 Feb;25(1):33-51. doi: 10.1055/s-2005-864780.

Treating hepatitis C in "difficult-to-treat" patients.

N Engl J Med. 2004 Jul 29;351(5):422-3. doi: 10.1056/NEJMp048068.

Efficacy and safety of combined treatment with pegylated-IFN-alpha 2b plus ribavirin in HIV-hepatitis C virus-co-infected patients.

AIDS. 2004 Apr 30;18(7):1079-80. doi: 10.1097/00002030-200404300-00021.

[PEG-interferons: significance for the treatment of viral hepatitis B and C].[聚乙二醇干扰素：对乙型和丙型病毒性肝炎治疗的意义]

Dtsch Med Wochenschr. 2001 Jun 1;126 Suppl 1:S68-75. doi: 10.1055/s-2001-14495.

Safety and efficacy of pegylated interferon and ribavirin in adolescents with human immunodeficiency virus and hepatitis C virus acquired perinatally.聚乙二醇干扰素和利巴韦林在围生期获得性人类免疫缺陷病毒和丙型肝炎病毒感染的青少年中的安全性和疗效。

J Med Virol. 2010 Jul;82(7):1110-4. doi: 10.1002/jmv.21802.

引用本文的文献

Real-world treatment outcomes of sofosbuvir-based regimens for treatment of chronic hepatitis C with and without human immunodeficiency virus co-infection.基于索磷布韦的治疗方案用于治疗合并或未合并人类免疫缺陷病毒感染的慢性丙型肝炎的真实世界治疗结果。

JGH Open. 2023 Jan 26;7(2):157-162. doi: 10.1002/jgh3.12869. eCollection 2023 Feb.

Real-World Clinical Efficacy and Tolerability of Direct-Acting Antivirals in Hepatitis C Monoinfection Compared to Hepatitis C/Human Immunodeficiency Virus Coinfection in a Community Care Setting.真实世界中直接作用抗病毒药物治疗丙型肝炎单感染与丙型肝炎/人类免疫缺陷病毒合并感染的临床疗效和耐受性比较：社区护理环境下的研究。

Gut Liver. 2018 Nov 15;12(6):694-703. doi: 10.5009/gnl18004.

Need to Face Liver Cirrhosis after HCV Cure with Antivirals.丙肝经抗病毒治疗治愈后需面对肝硬化问题。

EBioMedicine. 2017 Oct;24:24-25. doi: 10.1016/j.ebiom.2017.08.022. Epub 2017 Aug 25.

Forskolin, a hedgehog signalling inhibitor, attenuates carbon tetrachloride-induced liver fibrosis in rats.福司可林，一种刺猬信号通路抑制剂，可减轻四氯化碳诱导的大鼠肝纤维化。

Br J Pharmacol. 2016 Nov;173(22):3248-3260. doi: 10.1111/bph.13611. Epub 2016 Oct 4.

Genotypic distribution and hepatic fibrosis among HIV/HCV co-infected individuals in Southern China: a retrospective cross-sectional study.中国南方HIV/HCV合并感染个体的基因型分布与肝纤维化：一项回顾性横断面研究。

BMC Infect Dis. 2015 Sep 30;15:401. doi: 10.1186/s12879-015-1135-1.

Attenuation of early liver fibrosis by herbal compound "Diwu Yanggan" through modulating the balance between epithelial-to-mesenchymal transition and mesenchymal-to-epithelial transition.中药复方“地五养肝”通过调节上皮间质转化和间质上皮转化平衡来减轻早期肝纤维化。

BMC Complement Altern Med. 2014 Oct 27;14:418. doi: 10.1186/1472-6882-14-418.

HCV and HIV co-infection: mechanisms and management.丙型肝炎病毒和人类免疫缺陷病毒合并感染：机制与管理。

Nat Rev Gastroenterol Hepatol. 2014 Jun;11(6):362-71. doi: 10.1038/nrgastro.2014.17. Epub 2014 Feb 18.

Meta-analysis of the clinical value of danshen injection and huangqi injection in liver cirrhosis.丹参注射液与黄芪注射液治疗肝硬化的临床价值的 Meta 分析。

Evid Based Complement Alternat Med. 2013;2013:842824. doi: 10.1155/2013/842824. Epub 2013 Aug 28.

Update on HIV/HCV coinfection.HIV/HCV 合并感染的最新进展。

Curr HIV/AIDS Rep. 2013 Sep;10(3):226-34. doi: 10.1007/s11904-013-0169-5.

Hepatitis C virus infection: looking for interferon free regimens.丙型肝炎病毒感染：寻找无干扰素治疗方案。

ScientificWorldJournal. 2013 Apr 9;2013:825375. doi: 10.1155/2013/825375. Print 2013.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验